Results 191 to 200 of about 232,382 (353)
A rapid glass‐substrate 3D microfabrication method creates anatomically accurate carotid artery‐on‐a‐chip models from stroke patient scans in 2 h. These miniaturized devices replicate patient‐specific blood vessel geometry and flow patterns, enabling real‐time imaging of clot formation under controlled injury.
Yunduo Charles Zhao +14 more
wiley +1 more source
Platelet aggregation as a thrombotic marker in cirrhotic patients with portal vein thrombosis. [PDF]
Abdallah HM +6 more
europepmc +1 more source
Platelet Aggregation during and after General Anesthesia and Surgery
Karen M. Lichtenfeld +2 more
openalex +1 more source
Intravascular Platelet Aggregation in the Heart Induced by Stress [PDF]
Jacob I. Haft, Kazem Fani
openalex +1 more source
Nanostructured Protein Surfaces Inspired by Spider Silk
Harnessing recombinant spider silk technology, bioengineered spidroin variants enable the creation of functionalized nanostructured coatings with tunable affinity for specific targets, supporting a broad range of applications ‐ from antifouling surfaces and targeted drug delivery to advanced cell therapies and precision bio‐patterning via lithography ...
Martin Humenik, Thomas Scheibel
wiley +1 more source
Biological and biologically‐inspired functional nanostructures with structural, thermal, optical, and sensing applications are reviewed. The role of nanoscale features in biological materials on performance is described, and their blueprints are used for bio‐inspired nanomaterials, synthesized using advanced techniques (i.e., photolithography, bio ...
Chao Hsuan (Joseph) Sung +15 more
wiley +1 more source
Platelet aggregation and its modulation using antithrombotic agents. [PDF]
Srivastava N +5 more
europepmc +1 more source
Ionophore A-23187- and thrombin-induced platelet aggregation: independence from cycloxygenase products. [PDF]
E G Lapetina +2 more
openalex +1 more source
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source

